Pay in 4 interest-free payments of $5.58 Learn more
Ships within 48 hours · Estimated delivery Aug 28 - Sep 2
FSP1, a key resistance factor against ferroptosis, functions as a plasma membrane-associated redox enzyme that utilizes NADH to reduce CoQ10, thereby generating antioxidants and inhibiting lipid peroxidation
Dosing Comparison# Retatrutide Dosing# Based on Phase 2 trial data: Route : Once-weekly subcutaneous injection Dose range studied : 0.5 mg to 12 mg weekly Optimal dose : 12 mg weekly showed maximum efficacy in Phase 2 Titration : Gradual dose escalation over several weeks to manage GI tolerability Tirzepatide Dosing# Established FDA-approved dosing: Route : Once-weekly subcutaneous injection Starting dose : 2.5 mg weekly for 4 weeks Maintenance range : 5 mg, 10 mg, or 15 mg weekly Titration : 2.5 mg increments every 4 weeks to target dose Available formulations : Prefilled pens (Mounjaro/Zepbound) Tirzepatide's established titration protocol and prefilled pen delivery system offer practical advantages in clinical use
and dollar signs
Patients report improved mood, reduced anxiety, and greater self-esteem as they achieve their goals
US$ 25.09
US$ 21.39
US$ 24.12
US$ 23.98
US$ 27.56
US$ 23.84
